Brain Abnormalities Revealed in Late Preterm Infants Using MRI
|
By HospiMedica International staff writers Posted on 17 Jun 2014 |

Image: (a) Axial T2-weighted image shows deep gray nuclei (DGN) width, anteroposterior (AP) distance, and surface area. (b) Coronal T2- weighted image shows lateral ventricle atrial measures and transverse cerebellar diameter (TCD) (Photo courtesy of the Radiological Society of North America).
Infants born 32 to 36 weeks into gestation may have smaller brains and other brain defects that could lead to long-term developmental difficulties, according to a new imaging study.
A lot of the existing information on preterm birth and brain development has been gathered from studies of individuals born very preterm, or less than 32 weeks into gestation at birth.
For the new study, published online June 2014 in the journal Radiology, researchers in Australia focused on moderate and late preterm (MLPT) infants—those born between 32 weeks, zero days, and 36 weeks, six days, into gestation. MLPT babies account for approximately 80% of all preterm births and are responsible for much of the rise in the rates of preterm births over the last 20 years. In spite of this, up to now there have been no large-scale studies published on brain alterations linked with MLPT births that may offer clues into brain-behavior relationships in this group of children.
“In those very preterm babies, brain injury from bleeding into the brain or a lack of blood flow, oxygen or nutrition to the brain may explain some of the abnormal brain development that occurs,” said the study’s lead author, Jennifer M. Walsh, MBBCh, BAO., MRCPI, from the Royal Women’s Hospital (Melbourne, Australia). “However, in some preterm babies, there may be no obvious explanation for why their brain development appears slow compared with babies born on time.”
The researchers performed magnetic resonance imaging (MRI) scanning on 199 MLPT and 50 full-term-born infants (greater than 37 weeks gestation) between 38 to 44 weeks of gestation. They searched for symptoms of brain injury and compared the size and maturation of multiple brain structures in the two groups. Whereas injury rates were similar between the two groups, MLPT births were tied to smaller brain size at full-term-equivalent age. Furthermore, MLPT infants had less developed myelination in one part of the brain and more immature gyral folding compared with full term-born controls.
The findings suggest that MLPT births may disrupt the predicted course of brain growth that would normally occur in the last two or so months in utero, according to Dr. Walsh. “Given that brain growth is very rapid in the last one-third of pregnancy, it is perhaps not surprising that being born during this potentially vulnerable period may disrupt brain development,” she said.
The researchers are hoping to better determine the impact that moderate to late preterm birth has on the brain, so that they can then begin to try different treatments designed to enhance brain function and long-term outcome in these infants. “Medications, along with early intervention to help parents understand their baby’s needs, have been effective in helping very preterm babies catch up to their term-born peers,” Dr. Walsh said. “However, whether any of the existing treatments will help babies born between 32 and 36 weeks is unknown, as they have not been studied very much at all.”
The researchers plan to follow the infants in the study group through childhood to learn more about the relationship between brain abnormalities and later outcomes. They also are evaluating additional MRI information about brain structure and function in these children. “Understanding what problems they have and what might be causing them is the first step in trying to improve their long-term outcome,” Dr. Walsh said.
Related Links:
Royal Women’s Hospital
A lot of the existing information on preterm birth and brain development has been gathered from studies of individuals born very preterm, or less than 32 weeks into gestation at birth.
For the new study, published online June 2014 in the journal Radiology, researchers in Australia focused on moderate and late preterm (MLPT) infants—those born between 32 weeks, zero days, and 36 weeks, six days, into gestation. MLPT babies account for approximately 80% of all preterm births and are responsible for much of the rise in the rates of preterm births over the last 20 years. In spite of this, up to now there have been no large-scale studies published on brain alterations linked with MLPT births that may offer clues into brain-behavior relationships in this group of children.
“In those very preterm babies, brain injury from bleeding into the brain or a lack of blood flow, oxygen or nutrition to the brain may explain some of the abnormal brain development that occurs,” said the study’s lead author, Jennifer M. Walsh, MBBCh, BAO., MRCPI, from the Royal Women’s Hospital (Melbourne, Australia). “However, in some preterm babies, there may be no obvious explanation for why their brain development appears slow compared with babies born on time.”
The researchers performed magnetic resonance imaging (MRI) scanning on 199 MLPT and 50 full-term-born infants (greater than 37 weeks gestation) between 38 to 44 weeks of gestation. They searched for symptoms of brain injury and compared the size and maturation of multiple brain structures in the two groups. Whereas injury rates were similar between the two groups, MLPT births were tied to smaller brain size at full-term-equivalent age. Furthermore, MLPT infants had less developed myelination in one part of the brain and more immature gyral folding compared with full term-born controls.
The findings suggest that MLPT births may disrupt the predicted course of brain growth that would normally occur in the last two or so months in utero, according to Dr. Walsh. “Given that brain growth is very rapid in the last one-third of pregnancy, it is perhaps not surprising that being born during this potentially vulnerable period may disrupt brain development,” she said.
The researchers are hoping to better determine the impact that moderate to late preterm birth has on the brain, so that they can then begin to try different treatments designed to enhance brain function and long-term outcome in these infants. “Medications, along with early intervention to help parents understand their baby’s needs, have been effective in helping very preterm babies catch up to their term-born peers,” Dr. Walsh said. “However, whether any of the existing treatments will help babies born between 32 and 36 weeks is unknown, as they have not been studied very much at all.”
The researchers plan to follow the infants in the study group through childhood to learn more about the relationship between brain abnormalities and later outcomes. They also are evaluating additional MRI information about brain structure and function in these children. “Understanding what problems they have and what might be causing them is the first step in trying to improve their long-term outcome,” Dr. Walsh said.
Related Links:
Royal Women’s Hospital
Latest Critical Care News
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
- Cancer-Seeking Microbubbles Make Tumor Cells Self-Destruct
- Eye Movement Tests Uncover Hidden Brain Changes Years After Concussion
- Simple 5-Minute Questionnaire Test Speeds Endometriosis Diagnosis
Channels
Artificial Intelligence
view channel
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
AI Tool Maps Early Risk Patterns in Bloodstream Infections
Bloodstream infections can deteriorate rapidly and carry high mortality, especially in immunocompromised patients. Clinicians need reliable early risk stratification to prioritize monitoring and organ support.... Read moreCritical Care
view channel
AI Turns Glucose Data Into Actionable Insights for Diabetes Care
As continuous glucose monitoring becomes routine in diabetes care, the challenge is shifting from collecting numbers to interpreting them in ways that drive clinical decisions and patient behavior.... Read more4D Digital Twin Heart Model Improves CRT Outcomes
Cardiac resynchronization therapy can benefit patients with heart failure, yet up to one-third do not respond. Suboptimal placement of pacing leads remains a persistent barrier to response.... Read moreSurgical Techniques
view channel
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Handheld Robotic System Expands Options for Total Knee Surgery
Orthopedic teams vary in their adoption of robotics, with some surgeons favoring intraoperative decision-making and a manual instrument feel, while others rely on preoperative, computed tomography–based... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channelMedtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
Medtronic announced a multiyear renewal and significant expansion of its global strategic alliance with GE HealthCare across Patient Care Solutions. Building on more than three decades of collaboration,... Read more
Quantum Surgical Acquires NeuWave from Johnson & Johnson
Quantum Surgical announced that it has acquired NeuWave Medical from Johnson & Johnson. NeuWave’s microwave ablation system is used in percutaneous tumor ablation procedures, and the acquisition supports... Read more
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more







